|
On Wednesday evening, Stephen Lane - chairman, chief venture officer and co-founder of Ximedica - played host to a diverse group of more than 40 members of Rhode Island's emerging med-tech community to discuss strategies to enhance connectivity and collaboration.
more
By Richard Asinof |
|
Alexion Pharmaceuticals was hit with a warning letter from the U.S. Food and Drug Administration over its investigation of bacterial contamination at its Rhode Island facility, reported MarketWatch’s Health Exchange blog.
more
By PBN Staff
|
|
When President Obama announced his new $100 million Brain Research through Advancing Innovative Neurotechnologies initiative from the East Room at the White House on April 2, two Brown University professors, who had helped to plan this sweeping new vision for brain research, attended the ceremony.
more
By Richard Asinof |
|
An analysis of the new strain of what’s being called Shanghai bird flu, conducted by Dr. Anne S. De Groot and her team of researchers at EpiVax Inc., has concluded that there may be the need to develop a new vaccine to combat a potential devastating outbreak of the disease.
more
By Richard Asinof |
|
The Tech Collective and 41 other state bioscience associations have formed the Coalition of State Bioscience Institutes, a nationally coordinated effort aimed to help ensure U.S. leadership in bioscience innovation.
more
By Emily Greenhalgh |
|
According to the Battelle/Bio State Bioscience Industry Development Report, Rhode Island’s bioscience sector grew 44.3 percent from 2001 to 2010.
more
By Emily Greenhalgh |
|
Age: 36
more
7/23/12
|
|
Age: 33
more
7/23/12
|
|
President Barack Obama has proposed a $1 billion federal investment in advanced manufacturing and a group of congressmen from Rhode Island and Connecticut would like to see even more spent on boosting the sector in southern New England.
more
By Patrick Anderson |
|
Medical device maker Covidien LLC’s pharmaceutical arm, Mallinckrodt, has entered into a definitive agreement to acquire St. Paul, Minn.-based CNS Therapeutics Inc.
more
By PBN Staff
|